Advances in Intravitreal Injections
Posted by: Clemson Eye in News
By Donald Glaser, MDClemson Eye News, April 2015 There’s some good news for patients with diabetic macular edema (DME). Iluvien was recently approved by the FDA to treat DME. It’s an injectable micro-insert that provides sustained treatment for 36 months. The insert continuously delivers a sub-microgram dose of fluocinolone acetonide (FAc), a corticosteroid, for three […]
Read More